Mead, Gillian E,
Sposato, Luciano A,
Sampaio Silva, Gisele,
Yperzeele, Laetitia,
Wu, Simiao,
Kutlubaev, Mansur,
Cheyne, Joshua,
Wahab, Kolawole,
Urrutia, Victor C,
Sharma, Vijay K,
Sylaja, PN,
Hill, Kelvin,
Steiner, Thorsten,
David S, Liebeskind,
Rabinstein, lejandro A (2023) Organization (WSO) Guideline committee, under the auspices of the WSO, reviewed available guidelines.
Aims
Chu, Shuk Han,
Zhao, Xu,
Komber, Ahmad,
Cheyne, Joshua,
Wu, Simiao,
Cowey, Eileen,
Kutlubaev, Mansur,
Mead, Gillian (2023) by drug type and sensitivity analysis after excluding the trials at high risk of bias.
Secondary outcomes